Company / Cost of Revenue
RxSight, Inc. Cost of Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$35.3M
FY2025
5-year range
$13.0M / $35.3M
FY2021-FY2025
Trend
+27.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $28M to $35M over the past 2 years.
Based on SEC 10-K filings.
$35M in FY2025 with a 3-year CAGR of +25.0%.
Increased from $28M to $35M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +25.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +25.0%, indicating consistent growth.
- In FY2025, cost of revenue increased 27.6% year-over-year.
- Lowest cost of revenue in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.3M | +27.6% |
| FY2024 | $27.7M | +0.0% |
| FY2023 | $27.7M | +53.1% |
| FY2022 | $18.1M | +39.3% |
| FY2021 | $13.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026